期刊文献+

D1和D2式胃癌切除术后并发症对比研究 被引量:2

Comparative study of complications after D1 and D2 gastrectomy for gastric cancer
原文传递
导出
摘要 目的分析实施D1和D2式胃癌切除术后患者的早期并发症发生率和死亡率,进一步提高胃癌手术治疗的效果。方法收集2006年1月至2007年12月连续收治的实施D1或D2式胃癌切除术患者的临床资料,分析肿瘤临床病理特征、淋巴结廓清程度和术后早期并发症以及死亡率之间的关系。结果130例患者实施了胃癌切除术,D1式34例,D2式96例。D2式术后早期并发症发生率明显高于D1式(20.6%比39.6%,P〈0.05)。进一步分析单个并发症的发生情况,两种术式差异无统计学意义。D2式术后死亡率为4.2%(4/96),D1式为0(0/34),但差异无统计学意义(P〉0.05)。死亡患者4例,均为D2式切除术。与吻合口瘘、胰瘘等相关的肺部并发症是术后患者死亡的重要原因。结论D2式胃癌切除术是治疗胃癌安全有效的方法。淋巴结清除程度是增加术后并发症发生率和死亡率的因素。提高手术廓清技能和标准化胃癌淋巴结廓清术可能是减少术后早期并发症和死亡率的关键途径。 Objective To analyze the early mortality and morbidity of early postoperative complications of gastric cancer patients submitted to D1 or D2 gastrectomy for improving the surgical effect. Methods All consecutive patients who underwent D1 or D2 radical gastric resection between January 2006 and December 2007 were evaluated. Clinicopathologic features of the tumor, the extent of lymphadenectomy, the postoperative mortality and the early morbidity of complication were analysed. Results There were 130 patients admitted for the treatment of gastric cancer. 34 underwent D1 dissection and 96 underwent D2 dissection. The early morbidity of D2 dissection was higher than that of D1 dissection (20.6 % vs. 39.6 %, P 〈 0.05). When complications were analyzed individually, there was no significant difference. Although the postoperative mortality was higher in the D2 group, no significant difference was observed(4.2 % vs. 0, P 〉 0.05). 4 patients underwent D2 dissection died. Considering the causes of the 4 died patients, respiratory complication related to anastomotic and pancreatic leakage was the most important. Conclusion This study indicates that D2 dissection is a safe and effective procedure and the extent of lymphadenectomy may be related with high postoperative complication morbidity and mortality. Improving the surgical dissection skill and standardizing the gastric lymphad.enectomy are the key ways to decrease the morbidity and mortality.
出处 《肿瘤研究与临床》 CAS 2009年第2期95-97,共3页 Cancer Research and Clinic
关键词 胃肿瘤 胃切除术 淋巴结切除术 手术后并发症 死亡率 Stomach neoplasms Gastrectomy Lymph node excision Postoperative complications Mortality
  • 相关文献

参考文献16

  • 1Lee JS, Douglass HO. D2 dissection for gastric cancer. Surg Oncol, 1997, 6: 215-225.
  • 2Kim JP. Surgical results in gastric cancer. Semin Surg Oncol, 1999, 17: 132-138.
  • 3Viste A, Svanes K, Janssen CW, et al. Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer. Eur J Surg, 1994, 160:497-502.
  • 4Meyer HJ, Jahne J. Lymph node dissection for gastric cancer. Semin Surg Oncol, 1999,17:117-124.
  • 5Siewert JR, Bottcher K, Roder JD, et al. German Gastric Carcinoma. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Study Group BrJ Surg, 1993, 80: 1015-1018.
  • 6Bonenkamp JJ, Songun I, Hermans J, et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 dutch patients. Lancet, 1995, 345: 745-748.
  • 7Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet, 1996, 347: 995-999.
  • 8Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg, 1998, 228: 449-461.
  • 9Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer, 2002, 5: 1-5.
  • 10Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resection for gastric cancer. Lancet, 1996, 347: 995-999.

二级参考文献9

  • 1刘炳亚,朱正纲,林言箴.与胃癌患者预后相关的因素[J].中华胃肠外科杂志,2004,7(6):432-433. 被引量:5
  • 2DiLeo A,Pedrazzani C,Bonfiglio M,et al.Surperextended lymphadenectomy(D4) in the treatment of gastric adencarinoma[M].Minerva Chir,2002,57(5):641-647.
  • 3Nakane Y,Okumura S,Akehira K,et al.Jejunal pouch reconstruction after total gastectomy for cancer:A randomized controlled trial[J].Ann Surg,1995,222(1):27-35.
  • 4Bando E, Kojima N, Kawamura T, et al. Prognostic value of age andsex in early gastric cancer[J]. BrJ Surg, 2004, 91(9): 1197-1201.
  • 5de Manzoni G, Verlato G, Roviello F, et al. Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum [J]. Gastric Cancer,2003, 6(4): 237-242.
  • 6Kajiyama Y, Tsurumaru M, Udagawa H, et al. Prognostic factors inadenocarcinoma of the gastric cardia: pathologic stage analysis andmultivariate regression analysis [J]. J Clin Oncol, 1997, 15 (5):2015-2021.
  • 7Salvesen H B, Das S, Akslen L A. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a sub-group of aggressive endometrial carcinomas with poor prognosis [J].Clin Cancer Res, 2000, 6(1): 153-159.
  • 8Wu J F, Shao J C, Wang D B, et al. Expression and significance of cellcycle regulators in gastric carcinoma [J]. Aizheng, 2005, 24 (2):175-179.
  • 9武步强,陈广斌,李永国,肖鹏,白骏恒,秦君.p16和nm23-H1基因表达与胃癌及淋巴结转移的关系[J].外科理论与实践,2003,8(5):387-390. 被引量:1

共引文献5

同被引文献14

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部